Long term oral administration of this drug may cause high blood sugar level, therefore should periodically monitor blood glucose when administering this drug.
Diabetes patients, use as prescribed by the physician.
Glucosamine may enhance anti-coagulant activity of warfarin. Patients with combination therapy with glucosamine and warfarin should monitor INR level and be aware of bleeding.
Patients with an allergy to shellfish and shellfish products should avoid administering glucosamine.
Patients with asthma may be at risk for an asthma exacerbation when taking glucosamine-chondroitin sulfate.
Other Services
Country
Account